OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.710
+0.050 (3.01%)
Mar 9, 2026, 4:00 PM EDT - Market closed
OKYO Pharma Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 4.22 | 1.56 | 0.83 | 4.05 | 2.7 | 6.88 | Upgrade
|
| Cash & Short-Term Investments | 4.22 | 1.56 | 0.83 | 4.05 | 2.7 | 6.88 | Upgrade
|
| Cash Growth | 327.51% | 88.78% | -79.56% | 49.79% | -60.73% | 2807.98% | Upgrade
|
| Other Receivables | 0.02 | 1.89 | 0.58 | 0.98 | 0.88 | 0.08 | Upgrade
|
| Receivables | 0.02 | 1.89 | 0.58 | 0.98 | 0.88 | 0.08 | Upgrade
|
| Prepaid Expenses | 0.39 | 0.23 | 0.13 | 0.17 | 0.71 | 0.02 | Upgrade
|
| Total Current Assets | 4.64 | 3.68 | 1.54 | 5.2 | 4.3 | 6.97 | Upgrade
|
| Property, Plant & Equipment | 0 | 0 | 0 | 0.01 | 0.01 | 0.1 | Upgrade
|
| Total Assets | 4.64 | 3.68 | 1.54 | 5.2 | 4.3 | 7.08 | Upgrade
|
| Accounts Payable | 7.64 | 7.9 | 6.13 | 2.31 | 0.74 | 0.21 | Upgrade
|
| Accrued Expenses | - | 1.24 | 1.19 | 2.65 | 0.61 | 1.46 | Upgrade
|
| Short-Term Debt | 0.19 | - | - | 2.22 | - | - | Upgrade
|
| Current Portion of Leases | - | - | - | - | - | 0.03 | Upgrade
|
| Other Current Liabilities | 0.23 | 0.09 | 0.1 | 0.07 | - | - | Upgrade
|
| Total Current Liabilities | 8.06 | 9.23 | 7.42 | 7.26 | 1.35 | 1.7 | Upgrade
|
| Long-Term Leases | - | - | - | - | - | 0.06 | Upgrade
|
| Total Liabilities | 8.06 | 9.23 | 7.42 | 7.26 | 1.35 | 1.77 | Upgrade
|
| Additional Paid-In Capital | 151.23 | 146.72 | 143.11 | 131.39 | 123.98 | 91.91 | Upgrade
|
| Retained Earnings | -145.61 | -143.02 | -142.52 | -125.7 | -112.43 | -99.4 | Upgrade
|
| Comprehensive Income & Other | -9.03 | -9.24 | -6.47 | -7.74 | -8.6 | 12.8 | Upgrade
|
| Shareholders' Equity | -3.42 | -5.55 | -5.88 | -2.05 | 2.95 | 5.31 | Upgrade
|
| Total Liabilities & Equity | 4.64 | 3.68 | 1.54 | 5.2 | 4.3 | 7.08 | Upgrade
|
| Total Debt | 0.19 | - | - | 2.22 | - | 0.1 | Upgrade
|
| Net Cash (Debt) | 4.03 | 1.56 | 0.83 | 1.83 | 2.7 | 6.78 | Upgrade
|
| Net Cash Growth | 309.44% | 88.78% | -54.82% | -32.23% | -60.16% | 3211.98% | Upgrade
|
| Net Cash Per Share | 0.10 | 0.04 | 0.03 | 0.08 | 0.18 | 0.65 | Upgrade
|
| Filing Date Shares Outstanding | 38.45 | 37.61 | 33.84 | 25.55 | 21.14 | 10.35 | Upgrade
|
| Total Common Shares Outstanding | 38.45 | 36.02 | 33.34 | 25.52 | 21.14 | 10.35 | Upgrade
|
| Working Capital | -3.42 | -5.55 | -5.88 | -2.06 | 2.94 | 5.27 | Upgrade
|
| Book Value Per Share | -0.09 | -0.15 | -0.18 | -0.08 | 0.14 | 0.51 | Upgrade
|
| Tangible Book Value | -3.42 | -5.55 | -5.88 | -2.05 | 2.95 | 5.31 | Upgrade
|
| Tangible Book Value Per Share | -0.09 | -0.15 | -0.18 | -0.08 | 0.14 | 0.51 | Upgrade
|
| Machinery | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.